Figure 1: 4D quantum Hall system and the corresponding 2D topological charge pump. For a uniformly populated band in an infinite system, the centre-of-mass (COM) displacement during one cycle φ x = 0 ...
Monday, 4D Molecular Therapeutics FDMT released interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet age-related macular degeneration (wet AMD) patients. A single ...
Good morning, and welcome to the Jefferies 2025 Healthcare Conference. It's my pleasure now to introduce David Kirn, CEO; and Chris Simms, Chief Commercial Officer of 4D Molecular Therapeutics. All ...
4D Molecular Therapeutics (NASDAQ:FDMT) shares are trading higher after the company released interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet age-related ...
4D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedule Presented positive 60-week ...
4D-150 shows significant reduction in injection burden for wet AMD, with promising durability and tolerability in ongoing clinical trials. 4D Molecular Therapeutics has released positive interim ...
LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from ...
Adam Corsetti is a Commerce Writer from the United States. An avid gamer since childhood, Adam became hooked on video games after using the original Nintendo NES console. During college, he created a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback